Houston (1)

Malignant Supratentorial Neoplasm (1)

Recurrent Glioblastoma (1)

Recurrent Gliosarcoma (1)

Active, not recruiting (1)

phase 1 (1)

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

lonafarnib (1)

temozolomide (1)

drug (1)

Other (1)

Interventional (1)

malignant supratentorial neoplasm

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Dec 13, 2021